A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom

被引:0
作者
Daisuke Honda
Isao Ohsawa
Keiichi Iwanami
Hisaki Rinno
Yasuhiko Tomino
Yusuke Suzuki
机构
[1] Juntendo University,Department of Nephrology, Faculty of Medicine
[2] Saiyu Soka Hospital,Nephrology Unit, Internal Medicine
[3] Tokyo Bay Urayasu Ichikawa Medical Center,Department of Rheumatology
[4] Medical Corporation SHOWAKAI,undefined
来源
Clinical Journal of Gastroenterology | 2021年 / 14卷
关键词
Abdominal pain; Bradykinin; C1-inhibitor; Hereditary angioedema; Icatibant;
D O I
暂无
中图分类号
学科分类号
摘要
Hereditary angioedema due to C1-inhibitor deficiency (HAE-C1-INH) is a rare disease, which induces an acute attack of angioedema mediated by bradykinin. HAE-C1-INH can cause serious abdominal pain when severe edema develops in the gastrointestinal tract. However, because it takes a long time, 13.8 years on average in Japan, from the occurrence of the initial symptom to the diagnosis due to low awareness of the disease, undiagnosed HAE-C1-INH patients sometimes undergo unnecessary surgical procedures for severe abdominal pain. We herein present a 56-year-old patient with HAE-C1-INH, who underwent numerous abdominal operations. He frequently needed hospitalization with the administration of opioid due to severe abdominal pain. However, after he was accurately diagnosed with HAE-C1-INH at 55 years of age, he could start self-administration for an acute attack with icatibant, a selective bradykinin B2 receptor antagonist. Consequently, he did not need hospitalizing for ten months after the beginning of the treatment. A series of an accurate diagnosis and appropriate treatment for HAE-C1-INH improved his quality of life. Thus, HAE-C1-INH should be considered, when we meet patients with unidentified recurrent abdominal pain. This case highlights significance of an early diagnosis and appropriate treatment for HAE-C1-INH.
引用
收藏
页码:1175 / 1179
页数:4
相关论文
共 46 条
[1]  
Zuraw BL(2016)HAE Pathophysiology and underlying mechanisms Clin Rev Allergy Immunol 51 216-229
[2]  
Christiansen SC(2008)Hereditary angioedema N Engl J Med 359 1027-1036
[3]  
Zuraw BL(2012)Hereditary angio-oedema Lancet 379 474-481
[4]  
Longhurst H(2012)Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency J Allergy Clin Immunol 130 692-697
[5]  
Cicardi M(2018)Suffocation due to acute airway edema in a patient with hereditary angioedema highlighted the need for urgent improvements in treatment availability in Japan Intern Med 57 3193-3197
[6]  
Bork K(2006)Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 267-274
[7]  
Hardt J(2015)Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan Ann Allergy Asthma Immunol 114 492-498
[8]  
Witzke G(2018)The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures Allergy Asthma Clin Immunol 14 75-398
[9]  
Honda D(2016)Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting Ann Allergy Asthma Immunol 117 394-821
[10]  
Ohsawa I(2017)Complement factor C4 activation in patients with hereditary angioedema Clin Biochem 50 816-711